Qube Research & Technologies Ltd

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,398,777

-$9,607,983 QoQ

Shares Held

311,374

-39.4% QoQ

Ownership

0.373%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#58

of 383 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. PTCT ranks #24 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,398,777	311,374	-39.4%	Shares	Sole	2026-08-14
2026-03-31	$35,006,760	513,823	+19.2%	Shares	Sole	2026-05-15
2025-09-30	$26,446,419	430,934	+27.4%	Shares	Sole	2025-11-14
2025-06-30	$16,515,880	338,163	+14.0%	Shares	Sole	2025-08-14
2025-03-31	$15,113,054	296,567	+28.9%	Shares	Sole	2025-05-15
2024-12-31	$10,388,113	230,131	+171.5%	Shares	Sole	2025-02-14
2024-09-30	$3,144,187	84,749	+169.6%	Shares	Sole	2024-11-14
2024-03-31	$914,531	31,438	+200.1%	Shares	Sole	2024-05-14
2023-09-30	$234,767	10,476	-74.8%	Shares	Sole	2023-11-13
2022-09-30	$2,091,030	41,654	+218.8%	Shares	Sole	2022-11-14
2021-03-31	$618,675	13,066	+47.8%	Shares	Sole	2021-05-14
2020-12-31	$539,444	8,839	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.